Its turnover grew by 27.9% on the year to RON337.7 million.
Its operating income grew by 27.8% to RON338.8 million and its operating profit soared by 192.6% to RON53.6 million.
The Group’s total assets reached RON1.22 billion on March 31, 2020, up 3.2% on the year, while its total debts stood at RON918 million, similar with the level reported on December 31, 2020.
By business segments, the biggest revenues were generated by the medical clinics network, with sales of RON95.3 million in the first quarter of 2021, up 13.6% on the year, accounting for 28.2% of the group’s total sales. Hospitals generated revenues of RON78.2 million, up 37.2% on the year, laboratories saw a 75.4% increase in revenues to RON76.1 million on the year in the first quarter of 2021, while dental clinics had sales of RON22 million in the first three months of 2021, up 42.7% on the year.
The pharmacy division saw a decline of 10.6% in sales on the year to RON11.2 million in the first quarter of 2021, while the Group’s corporate sales reached RON50 million, up 5.6% from the year-earlier period.
In the first quarter of 2021, MedLife also increases existing facilities by EUR40 million by signing a syndicated loan of approximately EUR143 million, which will be used to consolidate and extend the group countrywide, by developing regional hospitals, according to company’s representatives.
MedLife, with a market value of RON1.58 billion, is 16.2% held by Mihail Marcu, majority shareholder holding the positions of CEO and Board Chairman, 14% held by Mihaela Gabriela Cristescu and 10.6% owned by Nicolae Marcu.
Its shares have been trading up 6.70% since the beginning of 2021, amid deals worth RON118 million.